Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — |
| Research & development | $13.4M | $11.1M | $6.8M | $5.7M | $255,000 | $133,000 |
| Operating expenses | $21.1M | $19.9M | $15.3M | $13.0M | $2.3M | $788,000 |
| Operating income | −$21.1M | −$19.9M | −$15.3M | −$13.0M | −$2.3M | −$788,000 |
| EBITDA | −$21.1M | −$19.9M | −$15.3M | −$13.0M | — | — |
| Net income | −$21.0M | −$19.4M | −$14.6M | −$13.0M | −$4.4M | −$1.1M |
| Basic EPSper basic share | -$0.62 | -$0.73 | -$0.72 | -$1.59 | -$1.03 | -$0.29 |
| Diluted EPSper diluted share | -$0.62 | -$0.73 | -$0.72 | -$1.59 | -$1.03 | -$0.29 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
ARMISTICE CAPITAL, LLC | 500K |
Clear Street Group Inc. | 16.61K |
D'Orazio & Associates, Inc. | 16K |
TWO SIGMA SECURITIES, LLC | 11.65K |
WELLS FARGO & COMPANY/MN | 7.5K |
UBS Group AG | 3.84K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.